GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (OTCPK:IBOGF) » Definitions » DeferredTaxAndRevenue

IBOGF (Universal Ibogaine) DeferredTaxAndRevenue : $0.22 Mil (As of Apr. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Universal Ibogaine's current deferred tax and revenue for the quarter that ended in Apr. 2024 was $0.22 Mil.

Universal Ibogaine DeferredTaxAndRevenue Historical Data

The historical data trend for Universal Ibogaine's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine DeferredTaxAndRevenue Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
DeferredTaxAndRevenue
Get a 7-Day Free Trial - - - 0.13 0.21

Universal Ibogaine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.21 0.18 0.26 0.22

Universal Ibogaine DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.